More precise and pervasive cybersecurity threat modeling during manufacturers’ development of medical devices – and also during the regulatory product review process – is critical for risk mitigation, says Kevin Fu, new acting director of medical device cybersecurity at the FDA. – Read More – DataBreachToday.com RSS Syndication


By |2021-04-09T19:18:50-04:00April 9th, 2021|